★ ANNUAL REVIEW 2027 SPONSORSHIPS NOW OPEN Learn more →

Log In | Become a Member | Sponsor | ⌕ Search

Compliance & EnforcementFCPA

Archive

FCPA

909 articles from the Compliance & Enforcement Brief.

Advertisement

Latest SEC FCPA Complaint Vulnerable to Dismissal

Key Considerations In The Timing Of FCPA Violation Disclosures

Will COVID-19 “Crony Charities” Trigger the Next Wave of FCPA Fumbles?

Pandemic May Not Boost FCPA Enforcement

SEC’s Recent FCPA Complaint May Reveal Benefits of Company Compliance but Pleadings May Be Deficient

Alexion Pharmaceuticals Strikes Tentative $25 Million Bribery Settlement

DOJ Declinations under FCPA Corporate Enforcement Policy

Antibribery Compliance Has to Continue, Officials Say

SEC Examinations and Enforcement in the COVID-19 Era

Recidivist Eni: Corruption, Controls, and Books and Records

Keeping Track of Current Events for Continuous Improvement

Um, About That Goldman FCPA Case…

Eni Settles FCPA Case and SEC Files Case Against Ex-Goldman Sachs Executive

Top 10 International Anti-Corruption Developments for March 2020

FCPA Landmines Beneath the Surface of the COVID-19 Crisis

Top 10 International Anti-Corruption Developments for February 2020

Judge Grants FCPA Defendants Baptiste and Boncy New Trials

Practice Alert: Is Every Email Another FCPA Violation?

Defendants Cannot Show that CMS Guidance Allows for Reimbursement of Travel that Never Occurred; United States Court of Appeals for the Fifth Circuit No. 18-20501. U.S. ex rel. Richard Drummond v. BestCare Laboratory Services L.L.C. and Karim A. Maghareh

Herbalife Sets Aside $40 Million for Bribery Settlement